Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23540)

• Formulation Name: Rolapitant Hydrochloride eq 166.5mg base/92.5ml Emulsion
• Company: Tersera

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Rolapitant	(DM8XP26)	Chemotherapy-induced nausea	MD90	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Disodium hydrogenorthophosphate	(E00283)	24203	Buffering agent; Complexing agent
Glyceryl monolinoleate	(E00639)	Not Available	Other agent
Medium-chain triglyceride	(E00640)	Not Available	Emollient; Lubricant; Surfactant
Polyoxyl 15 hydroxystearate	(E00659)	Not Available	Emulsifying agent; Solubilizing agent; Surfactant
Sodium chloride	(E00077)	5234	Diluent; Tonicity agent
Water	(E00035)	962	Solvent